Published in Transplantation on January 27, 2001
Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation. World J Gastroenterol (2013) 0.77
Challenges of recurrent hepatitis C in the liver transplant patient. World J Gastroenterol (2014) 0.77
Antihepatitis C virus therapy in liver transplanted patients. Ther Clin Risk Manag (2006) 0.75
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science (1998) 10.43
Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology (1997) 5.26
Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol (1998) 4.52
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA (1999) 3.60
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med (1993) 3.51
Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med (1978) 3.28
Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem (2000) 2.47
Country profile: India. Lancet (1998) 2.40
Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests. Clin Chem (2000) 2.30
The beneficial effect of delayed compressive loading on tissue-engineered cartilage constructs cultured with TGF-beta3. Osteoarthritis Cartilage (2007) 2.26
Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Res Treat (2001) 2.26
Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa. Hepatology (1997) 2.23
Involvement of the family members in caring of patients an acute care setting. J Postgrad Med (2014) 2.18
A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase. Science (1990) 2.16
Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene (2010) 2.10
Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol (2001) 1.92
Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res (2001) 1.87
Pseudomelanosis duodeni: associated with multiple clinical conditions and unpredictable iron stainability - a case series. Endoscopy (2008) 1.75
Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy. J Virol (2001) 1.74
Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol (1999) 1.70
Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone (1999) 1.66
Clinical and economic outcomes of individuals with severe peptic ulcer hemorrhage and nonbleeding visible vessel: an analysis of two prospective clinical trials. Am J Gastroenterol (1998) 1.66
Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol (1999) 1.64
Lichen planus pigmentosus. J Am Acad Dermatol (1989) 1.64
Adult living donor liver transplantation: Preferences about donation outside the medical community. Liver Transpl (2001) 1.59
Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology (1999) 1.59
HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J Virol (1993) 1.58
Use of the AST to platelet ratio index in HCV/HIV co-infected patients. Aliment Pharmacol Ther (2011) 1.57
Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy (2004) 1.57
Characterization of glucokinase regulatory protein-deficient mice. J Biol Chem (2000) 1.56
Ophiasis inversus: a rare pattern of alopecia areata. Pediatr Dermatol (1998) 1.54
Development and evaluation of the Liver Disease Quality of Life instrument in persons with advanced, chronic liver disease--the LDQOL 1.0. Am J Gastroenterol (2000) 1.53
Superficial granulomatous pyoderma: an idiopathic granulomatous cutaneous ulceration. J Eur Acad Dermatol Venereol (2002) 1.53
Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy. Science (1983) 1.52
Resolution of cirrhosis in autoimmune hepatitis with corticosteroid therapy. J Clin Gastroenterol (2001) 1.49
Re-treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40 kDa) and ribavirin. J Viral Hepat (2006) 1.48
Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J Pharmacol Exp Ther (2001) 1.46
Herpes simplex virus hepatitis: expanding the spectrum of disease. Transpl Infect Dis (2006) 1.46
Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol (1998) 1.46
GEISHA: an in situ hybridization gene expression resource for the chicken embryo. Cytogenet Genome Res (2007) 1.46
Keratitis, ichthyosis, deafness (KID) syndrome--the first report from India. Clin Exp Dermatol (1993) 1.43
Renal manifestations of hepatitis C virus infection. Kidney Int (1994) 1.43
Oral lesions of lichen planus. Int J Dermatol (1993) 1.41
Reliability and validity of a brief physical activity assessment for use by family doctors. Br J Sports Med (2005) 1.41
Severe upper gastrointestinal tumor bleeding: endoscopic findings, treatment, and outcome. Endoscopy (1996) 1.40
Resolution of chronic anal fissures after treatment of contiguous internal hemorrhoids with direct current probe. Gastrointest Endosc (1997) 1.40
Odor in pemphigus. Dermatology (1992) 1.40
Early results of laparoscopic intraperitoneal onlay mesh repair for inguinal hernia. Br J Surg (1994) 1.39
Reduction of bleeding after heart operations through the prophylactic use of epsilon-aminocaproic acid. J Thorac Cardiovasc Surg (1996) 1.39
Pemphigus in pregnancy. Am J Obstet Gynecol (1989) 1.39
Separation of an overtube from the bite block during band ligation of esophageal varices. Gastrointest Endosc (1997) 1.39
Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. J Med Virol (1997) 1.37
Gsh-1: a novel murine homeobox gene expressed in the central nervous system. Dev Dyn (1995) 1.37
Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology (1999) 1.35
Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy. J Virol (2000) 1.32
Structure of the 5' flanking region of the gene encoding human parathyroid-hormone-related protein (PTHrP). Gene (1989) 1.31
Hepatitis in marmosets: induction of disease with coded specimens from a human volunteer study. Science (1969) 1.30
Gsh-4 encodes a LIM-type homeodomain, is expressed in the developing central nervous system and is required for early postnatal survival. EMBO J (1994) 1.25
Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group. Hepatology (1997) 1.25
Transmission of the hepatitis-C virus by tissue transplantation. J Bone Joint Surg Am (1995) 1.24
The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med (1996) 1.24
Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests. J Clin Microbiol (2001) 1.22
Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin. Nat Commun (2013) 1.20
A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C. J Viral Hepat (2012) 1.19
Concomitant occurrence of leprosy and tuberculosis--a clinical, bacteriological and radiological evaluation. Lepr India (1982) 1.19
Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin. Br J Cancer (2009) 1.17
Anti-inflammatory activity of Euphorbia acaulis Roxb. J Ethnopharmacol (1984) 1.16
The granulin/epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro. J Biol Chem (1998) 1.15
Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin. Calcif Tissue Int (1985) 1.14
Influence of decreasing nutrient path length on the development of engineered cartilage. Osteoarthritis Cartilage (2008) 1.14
The use of biotinylated monoclonal antibodies and streptavidin affinity chromatography to isolate herpesvirus hydrophobic proteins or glycoproteins. Anal Biochem (1987) 1.14
Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int (1994) 1.14
Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing. J Gen Virol (1995) 1.13
Response of preterm infants to hepatitis B vaccine. J Pediatr (1992) 1.13
Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology (1997) 1.10
Nutritional status of adolescents in rural Wardha. Indian J Pediatr (2006) 1.10
Randomized, prospective study of cyanoacrylate injection, sclerotherapy, or rubber band ligation for endoscopic hemostasis of bleeding canine gastric varices. Gastrointest Endosc (1995) 1.10
Computer-assisted electrocoagulation: bipolar vs. monopolar in the treatment of experimental canine gastric ulcer bleeding. Gastroenterology (1981) 1.09
Multifocal granular cell tumor of the esophagus and proximal stomach with infiltrative pattern: a case report and review of the literature. Arch Pathol Lab Med (1999) 1.09
In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease. J Virol (2000) 1.09
The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats. Neuroscience (2007) 1.09
Microscopic electronic inhomogeneity in the high-Tc superconductor Bi2Sr2CaCu2O8+x. Nature (2001) 1.09
Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J Infect Dis (1997) 1.09
Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol (1995) 1.08
In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo. J Bone Miner Res (1994) 1.08
Relationship of anthropometric indicators with blood pressure levels in rural Wardha. Indian J Med Res (2006) 1.08
Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes. J Virol (1996) 1.08
Identification of 10 murine homeobox genes. Proc Natl Acad Sci U S A (1991) 1.07
Management of upper gastrointestinal bleeding in the patient with chronic liver disease. Med Clin North Am (1996) 1.07
Comparison of reliability of lateral cephalogram and computed tomography for assessment of airway space. Niger J Clin Pract (2014) 1.06
Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem (1994) 1.06
Direct growth of aligned carbon nanotubes on bulk metals. Nat Nanotechnol (2006) 1.06
Pretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis C. J Viral Hepat (2000) 1.06